Get the Stockscreener App
102.96
1.94%
1.96
After Hours:
102.44
-0.52
-0.51%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $102.96, with a volume of 8.58M.
It is up +1.94% in the last 24 hours and up +6.52% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$101.00
Open:
$101.66
24h Volume:
8.58M
Relative Volume:
1.24
Market Cap:
$132.00B
Revenue:
$34.76B
Net Income/Loss:
$4.79B
P/E Ratio:
27.81
EPS:
3.7017
Net Cash Flow:
$5.21B
1W Performance:
+2.06%
1M Performance:
+6.52%
6M Performance:
+12.35%
1Y Performance:
+11.93%
1-Day Range:
$101.28
$103.02
1-Week Range:
$99.68
$103.02
52-Week Range:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
102.96 | 129.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
ABT
Abbott Laboratories
|
109.30 | 184.48B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.56 | 135.49B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
93.53 | 136.93B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
EW
Edwards Lifesciences Corp
|
81.36 | 47.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic reports positive post-market findings for Penditure LAA exclusion device - MassDevice
Lingohr Asset Management GmbH Has $5.34 Million Stock Position in Medtronic PLC $MDT - MarketBeat
National Pension Service Raises Holdings in Medtronic PLC $MDT - MarketBeat
How Medtronic’s Ambulatory Surgery Center Push With Mindray (MDT) Has Changed Its Investment Story - Yahoo Finance UK
Survey on RDN procedure volumes fuels optimism for Medtronic (MDT) - MSN
Survey on RDN Procedure Volumes Fuels Optimism for Medtronic (MDT) - Finviz
Medtronic (NYSE:MDT) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Medtronic (MDT) Rated Overweight with $114 Price Target by Wells Fargo - GuruFocus
Orthopedic Implants Market Outlook 2025–2034 - GlobeNewswire Inc.
Townsquare Capital LLC Sells 12,273 Shares of Medtronic PLC $MDT - MarketBeat
Mirae Asset Global Investments Co. Ltd. Acquires 41,339 Shares of Medtronic PLC $MDT - MarketBeat
CICC Initiates Medtronic at Outperform With $121 Price Target - marketscreener.com
AustralianSuper Pty Ltd Purchases Shares of 163,356 Medtronic PLC $MDT - MarketBeat
The Truth About Medtronic plc: Is This Sleepy Giant Your Smartest Boring Investment Play? - AD HOC NEWS
Stretchable and Conformal Electronics Market Forecast to Cross $6 Billion by 2030: Smart Wearables Propel GrowthPanasonic, Medtronic, and LG Dominate - Yahoo Finance Singapore
New York State Common Retirement Fund Cuts Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Flossbach Von Storch SE - MarketBeat
Medtronic pumps $90M into Anteris TAVR program - BioWorld MedTech
Truist Financial Corp Buys 168,439 Shares of Medtronic PLC $MDT - MarketBeat
Lbp Am Sa Cuts Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Cambiar Investors LLC - MarketBeat
Medtronic PLC (NYSE:MDT) Shows High-Probability Technical Breakout Setup - Chartmill
Core Alternative Capital Has $5.33 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medical Device Design Market Is Going to Boom |• Medtronic • Johnson & Johnson • Abbott Laboratories - openPR.com
Compass Wealth Management LLC Reduces Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Acquired by Bank of New York Mellon Corp - MarketBeat
Medtronic Rival's VP Says Docs Praised Device But Didn't Buy - Law360
What's Driving the Market Sentiment Around Medtronic PLC? - Benzinga
Medtronic targets ASCs with extended Mindray collaboration - MedTech Dive
Medtronic PLC $MDT Position Trimmed by Phoenix Financial Ltd. - MarketBeat
Medtronic PLC $MDT Shares Acquired by Vanguard Personalized Indexing Management LLC - MarketBeat
Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation - Pharmabiz.com
Medtronic Investors Ask 8th Circ. To Revive Insulin Pump Suit - Law360
Medtronic Sphere-360 PFA catheter lands CE mark - BioWorld MedTech
10 Years of Medtronic’s Micra Leadless Pacemaker - Medical Device and Diagnostic industry
60+ CEOs Call for ‘Immediate Deescalation’ in Minneapolis - Medical Device and Diagnostic industry
Medtronic, Mindray broaden strategic partnership into ASCs - MassDevice
Medtronic wins CE mark for single-shot pulsed field ablation catheter - MedTech Dive
Medtronic Plc (MDT) Stock Analysis: Strong Buy Signals Amidst A 9.24% Upside Potential - DirectorsTalk Interviews
Medtronic PLC $MDT Shares Purchased by Monte Financial Group LLC - MarketBeat
Parthenon LLC Reduces Position in Medtronic PLC $MDT - MarketBeat
Caterpillar, Medtronic, Transocean And A Financial Stock: CNBC's 'Final Trades' - Benzinga
Medtronic wins CE mark for Affera Sphere-360 PFA catheter, reports first U.S. IDE cases - MassDevice
Intact Investment Management Inc. Buys 53,300 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic calls for ‘deescalation’ after federal agents kill nurse - MassDevice
Sector Gamma AS Grows Stake in Medtronic PLC $MDT - MarketBeat
How The New Price Target Is Shaping The Medtronic (MDT) Investment Story - Yahoo Finance UK
Mitsubishi UFJ Trust & Banking Corp Raises Holdings in Medtronic PLC $MDT - MarketBeat
Resona Asset Management Co. Ltd. Sells 25,090 Shares of Medtronic PLC $MDT - MarketBeat
Cullen Frost Bankers Inc. Reduces Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Stock Position Trimmed by CIBC Asset Management Inc - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):